Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 92.58-57.38-14.14442.89-51.19

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is 92.58 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202492.58
Mar2023-57.38
Mar2022-14.14
Mar2021442.89
Mar2020-51.19

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14
Negative
Mar2021 442.89
Positive
Mar2020 -51.19 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,174.0 Cr 0.5% 3.7% -5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

0.5%

3.7%

-5.7%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses